Strides Pharma Science Limited (STAR) Share Analysis
NSE · Healthcare · Healthcare
Strides Pharma Science Limited (NSE: STAR) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹1,015.00, P/E 16.2, ROE 20%.
Get the AI verdict on STAR: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
STAR chart with trendlines
Is STAR a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Strides Pharma Science Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
STAR key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,015.00 |
| Market cap | ₹9,353 Cr |
| P/E ratio | 16.2 |
| P/B ratio | 2.74 |
| EPS | ₹66.92 |
| Book value per share | ₹371.00 |
| Dividend yield | 0.49% |
| 52-week range | |
| 52-week high | ₹1,260.90 |
| 52-week low | ₹768.65 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 29% |
| FIIs | 27.98% |
| DIIs | 15.51% |
| Public | 27.52% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.